Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

46.92
-0.0900-0.19%
Post-market: 47.050.1300+0.28%16:57 EDT
Volume:7.02M
Turnover:330.10M
Market Cap:95.49B
PE:17.57
High:47.27
Open:47.21
Low:46.70
Close:47.01
Loading ...

BlackRock Adjusts Holdings in Bloomsbury Publishing

TIPRANKS
·
Yesterday

BRIEF-Bristol-Myers Squibb Co Says Prelim Q2 Total Acquired IPRD & Licensing Income For $1,494 Mln

Reuters
·
Yesterday

Bristol-Myers Squibb Co -Prelim Total Acquired Iprd and Licensing Income for Three Months Ended June 30 $1,494 Mln

THOMSON REUTERS
·
Yesterday

Bristol-Myers Squibb’s Deucravacitinib Study: A Boost for Psoriasis Treatment

TIPRANKS
·
Yesterday

Bristol-Myers Squibb’s New Study: A Potential Game Changer in Leukemia Treatment

TIPRANKS
·
03 Jul

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
02 Jul

Health Rounds: 3D printed insulin-producing cells show promise for type 1 diabetes in lab tests

Reuters
·
02 Jul

Bristol-Myers Squibb: Hold Rating Amid Slower Growth and Stable Valuation

TIPRANKS
·
30 Jun

Bristol-Myers Squibb’s Promising Cancer Study: A Closer Look

TIPRANKS
·
28 Jun

FDA Approves Streamlined Monitoring and Removal of REMS for Bristol Myers Squibb’s CAR T Cell Therapies, Enhancing Patient Access

Reuters
·
27 Jun

U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of Rems Programs Within Bristol Myers Squibb’s Cell Therapy Labels

THOMSON REUTERS
·
27 Jun

Cigna Files Antitrust Lawsuit Accusing Bristol Myers of Illegally Extending Monopoly on Pomalyst Multiple Myeloma Drug, Causing Purchasers to Overpay, Court Filing Shows

THOMSON REUTERS
·
24 Jun

Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst

Reuters
·
24 Jun

ONO Pharmaceutical and Bristol-Myers Squibb KK Receive Supplemental Approval in Japan for Opdivo® and Yervoy® Combination Therapy for Unresectable Hepatocellular Carcinoma

Reuters
·
24 Jun

What's Behind The 'Stupid' Earnings Flood -- Barron's

Dow Jones
·
24 Jun

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), OmniAb (OABI) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
23 Jun

Bristol-Myers Squibb (BMY) Gets a Hold from Bernstein

TIPRANKS
·
20 Jun

Prothena Corporation Announces Phase 3 Advancement of Prasinezumab for Early-Stage Parkinson's Disease

Reuters
·
19 Jun

BRIEF-Bristol Myers Squibb announces dividend

Reuters
·
18 Jun

Bristol-Myers Squibb Keeps Quarterly Dividend at $0.62 per Share; Payable Aug. 1 to Shareholders of Record on July 3

MT Newswires Live
·
18 Jun